Whole‐Exome Sequencing for Diagnostic Investigation of 267 Patients From the Brazilian Public Health System ( SUS ) Followed by Reanalysis of Nondiagnostic Cases

Although advances in genetic testing in recent years have improved patient care, especially regarding rare diseases, the path to molecular diagnosis remains lengthy for many patients in Brazil, particularly among families who rely exclusively on the public health system. Between 2017 and 2023, a total of 267 patients with suspected rare diseases were recruited from the Genetics Unit of the Instituto da Criança do Hospital das Clínicas da Universidade de São Paulo; blood samples from the probands and, when available, their parents were sent to Yokohama City University and submitted to whole-exome sequencing (WES). Among the 267 cases, 124 (46.4%) received molecular diagnostic findings; most of these patients had intellectual disability or developmental delay. In addition, 130 cases (48.6%) were classified as "no relevant variant identified" and another 13 cases (4.8%) were considered inconclusive; all underwent reanalysis of WES data, which led to a molecular diagnosis in 10 additional cases (7%) previously undetected, primarily through newly established gene-disease associations or updated interpretations of previously identified variants. Our diagnostic yield (46.4%) was consistent with those reported in large cohorts and meta-analysis published internationally. However, nondiagnostic results warrant further consideration and WES reanalysis should be considered as a strategy to improve diagnostic outcomes, even if mostly through periodic literature reviews and variant reinterpretation.

Authors

Institutions

Publication Details

Journal
Clinical Genetics
Published
2026-11-20
DOI
https://doi.org/10.1111/cge.70281
Primary Topic
Genomics and Rare Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Whole‐Exome Sequencing for Diagnostic Investigation of 267 Patients From the Brazilian Public Health System ( SUS ) Followed by Reanalysis of Nondiagnostic Cases

Bruno de Oliveira Stephan, Eriko Koshimizu, Matheus Augusto Araújo Castro, Débora Romeo Bertola et al.
Clinical Genetics
Genomics and Rare Diseases
article

Whole‐Exome Sequencing for Diagnostic Investigation of 267 Patients From the Brazilian Public Health System ( SUS ) Followed by Reanalysis of Nondiagnostic Cases

Bruno de Oliveira Stephan, Eriko Koshimizu, Matheus Augusto Araújo Castro, Débora Romeo Bertola, Rachel Sayuri Honjo, Caroline Brandão Piai, Caio Robledo D’Angioli Costa Quaio, Naomichi Matsumoto, Chong Ae Kim, Vitória Pelegrino do Val, Juliana Duque Leão, Débora Sotyrios Souza Pegos
article en

Abstract

Although advances in genetic testing in recent years have improved patient care, especially regarding rare diseases, the path to molecular diagnosis remains lengthy for many patients in Brazil, particularly among families who rely exclusively on the public health system. Between 2017 and 2023, a total of 267 patients with suspected rare diseases were recruited from the Genetics Unit of the Instituto da Criança do Hospital das Clínicas da Universidade de São Paulo; blood samples from the probands and, when available, their parents were sent to Yokohama City University and submitted to whole-exome sequencing (WES). Among the 267 cases, 124 (46.4%) received molecular diagnostic findings; most of these patients had intellectual disability or developmental delay. In addition, 130 cases (48.6%) were classified as "no relevant variant identified" and another 13 cases (4.8%) were considered inconclusive; all underwent reanalysis of WES data, which led to a molecular diagnosis in 10 additional cases (7%) previously undetected, primarily through newly established gene-disease associations or updated interpretations of previously identified variants. Our diagnostic yield (46.4%) was consistent with those reported in large cohorts and meta-analysis published internationally. However, nondiagnostic results warrant further consideration and WES reanalysis should be considered as a strategy to improve diagnostic outcomes, even if mostly through periodic literature reviews and variant reinterpretation.

Clinical Genetics
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (BR), Yokohama City University (JP)
Genomics and Rare Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon